Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Apr 3;25(1):48.
doi: 10.1186/s40644-025-00861-5.

Comparison of the diagnostic accuracy of enhanced-CT and double contrast-enhanced ultrasound for preoperative T-staging of gastric cancer: a meta-analysis

Affiliations
Meta-Analysis

Comparison of the diagnostic accuracy of enhanced-CT and double contrast-enhanced ultrasound for preoperative T-staging of gastric cancer: a meta-analysis

MingYue Lv et al. Cancer Imaging. .

Abstract

Background: Accurate preoperative staging of gastric cancer (GC) depends on effective diagnostic methods. Enhanced computed tomography (enhanced-CT) is a widely used and reliable preoperative assessment tool for GC, Double Contrast-Enhanced Ultrasound (DCEUS) can display the structure and layers of the gastric wall more accurately, and has high sensitivity (SE) and specificity (SP).

Objective: The present study aims to conduct a comprehensive meta-analysis comparing the preoperative T-staging accuracy of DCEUS and enhanced-CT.

Methods: A systematic literature search was conducted across PubMed, Embase, Web of Science, and Cochrane Library to identify eligible articles from inception to February 19, 2024. The study included both prospective and retrospective studies involving patients with GC who underwent DCEUS or enhanced-CT. This encompassed studies utilizing comparative diagnostic test accuracy (CDTA) with both DCEUS and enhanced-CT, as well as studies employing single diagnostic test accuracy (SDTA) with either DCEUS or enhanced-CT alone. Risk of bias was assessed using the Quality Assessment Of Diagnostic Accuracy Studies-C (QUADAS-C) and Assessment Of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. The quality of evidence for each outcome was assessed using GRADE (Grading of Recommendations Assessment, Development and Evaluation).

Results: A total of 39 studies involving 6,374 patients were included in this meta-analysis. Among these, 3 studies (319 patients) directly compared dynamic contrast-enhanced ultrasound (DCEUS) and enhanced computed tomography (CT), while 31 studies (5,180 patients) evaluated enhanced CT alone, and 5 studies (875 patients) assessed DCEUS alone. For the direct comparison studies (CDTA), DCEUS demonstrated higher sensitivity (SE) and specificity (SP) for T1-T4 staging compared to enhanced CT, with moderate to low certainty of evidence. Specifically, DCEUS showed superior performance in detecting early-stage (T1) and advanced-stage (T4) tumors. Enhanced CT, while effective, had lower sensitivity across all stages, particularly for T1 tumors. In the single-modality studies (SDTA), DCEUS consistently showed higher sensitivity for T2-T4 staging compared to enhanced CT, with comparable specificity. However, the certainty of evidence for indirect comparisons was very low, highlighting the need for further high-quality comparative studies. Overall, DCEUS appears to be a promising modality for gastric cancer T staging, particularly for early-stage detection, but the limited number of direct comparative studies underscores the need for more robust evidence.

Conclusion: Current evidence indicates that DCEUS significantly outperforms enhanced-CT in terms of SE and diagnostic accuracy for preoperative T-staging of GC, while maintaining comparable SP. However, these findings require further validation through rigorous studies with larger sample sizes and improved methodological quality.

Keywords: Computer tomography; Double contrast-enhanced ultrasound; GRADE; Gastric cancer; Tumor staging.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow chart of the literature retrieval
Fig. 2
Fig. 2
QUADAS. A The quality of 3 CDTA studies (Evaluated by QUADAS-C). B The quality of 31 SDTA studies with enhanced CT, summarises the risk of bias and applicability issues for the studies (Evaluated by QUADAS-2). C The quality of 5 SDTA studies with DCEUS, summarises the risk of bias and applicability issues for the studies (Evaluated by QUADAS-2). Detailed results are displayed in Figure S2
Fig. 3
Fig. 3
Pooled SE and SP in T1 staging of DCEUS and enhanced-CT. SE: sensitivity; SP: specificity; CT, computed tomography; DCEUS, double contrast-enhanced ultrasound
Fig. 4
Fig. 4
SROC curves for all studies at each stage of T1, T2, T3, T4. 1. A DCEUS for T1, T2, T3, T4 staging of gastric cancer; (B) enhanced-CT for T1, T2, T3, T4 staging of gastric cancer; CT, computed tomography; DCEUS, double contrast enhanced ultrasound. SROC, summary receiver operating characteristic
Fig. 5
Fig. 5
Pooled SE and SP in T2 staging of DCEUS and enhanced-CT. SE: sensitivity; SP: specificity; CT, computed tomography; DCEUS, double contrast-enhanced ultrasound
Fig. 6
Fig. 6
Pooled SE and SP in T3 staging of DCEUS and enhanced-CT. SE: sensitivity; SP: specificity; CT, computed tomography; DCEUS, double contrast-enhanced ultrasound
Fig. 7
Fig. 7
Pooled SE and SP in T4 staging of DCEUS and enhanced-CT. SE: sensitivity; SP: specificity; CT, computed tomography; DCEUS, double contrast-enhanced ultrasound

Similar articles

References

    1. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–48. - PubMed
    1. Zhu Z, Gong Y, Xu H. Clinical and pathological staging of gastric cancer: current perspectives and implications. Eur J Surg Oncol. 2020;46(10 Pt B):e14–9. - PubMed
    1. Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23. 10.1007/s10120-011-0042-4. - PubMed
    1. Lee MH, Choi D, Park MJ, Lee MW. Gastric cancer: imaging and staging with MDCT based on the 7th AJCC guidelines. Abdom Imaging. 2012;37(4):531–40. - PubMed
    1. In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the National cancer database. Ann Surg Oncol. 2017;24(12):3683–91. - PubMed